Xeris Biopharma (XERS) announced that Anh Nguyen has joined Xeris as chief medical officer succeeding Ken Johnson who will retire April 1. Nguyen will develop and lead the entire product portfolio vision and strategic direction for the medical, regulatory, preclinical and clinical development, and pharmacovigilance functions, reporting to John Shannon, Xeris’ CEO.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XERS:
Questions or Comments about the article? Write to editor@tipranks.com